Merck KGaA Wants Brookstone's 'False Generic' Yanked
A subsidiary of German pharmaceutical company Merck KGaA is seeking an injunction barring generics maker Brookstone Pharmaceuticals LLC from selling prenatal nutritional supplements that Merck claims are being falsely marketed as...To view the full article, register now.
Already a subscriber? Click here to view full article